| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |